Changes in United States heart allocation: A community energized to improve policy

Joseph G Rogers1

  • 1Division of Cardiology, Duke University, Durham, NC.

Insights

The United Network for Organ Sharing (UNOS) is updating heart transplant policies to better match donor hearts with critically ill patients. This change aims to improve access and prioritize those at highest risk of dying while waiting for a transplant.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Health Policy

Background:

  • Current donor heart allocation in the U.S. has not kept pace with evolving patient demographics and medical advancements.
  • Increasing numbers of patients with advanced heart failure face limited donor availability and regional disparities in access to care.

Purpose of the Study:

  • To address the stagnation in donor heart allocation by re-evaluating patient prioritization and organ sharing protocols.
  • To propose a new policy that enhances equity and efficiency in the heart transplant waiting list process.

Main Methods:

  • The United Network for Organ Sharing (UNOS) Thoracic Committee reviewed existing allocation criteria and patient data.
  • A new policy was developed to stratify patients more granularly based on wait-list mortality risk.
  • The policy proposes expanding geographic boundaries for organ sharing.

Main Results:

  • The proposed policy introduces a more refined patient stratification system.
  • It aims to increase access to donor hearts for the sickest patients on the waiting list.
  • The policy seeks to mitigate regional disparities in heart transplantation.

Conclusions:

  • The revised UNOS policy is designed to improve donor heart allocation by prioritizing patients based on their immediate need and risk of mortality.
  • Expanding organ sharing regions is a key component to ensure equitable access for critically ill heart failure patients awaiting transplantation.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
498
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
705
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
459
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.8K